• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Imaging and Intervention

Attenuation values may help differentiate renal neoplasm from simple cyst on contrast-enhanced CT

byJames RoebkerandDavid Wang
April 9, 2017
in Imaging and Intervention, Nephrology, Oncology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In a retrospective review of 125 patients with primary renal cell neoplasm that underwent computed tomography (CT), simple renal cysts were found to have a mean attenuation value up to 30 Hounsfield Units (HU) on contrast-enhanced CT, while the lowest attenuation value of homogenous renal cell neoplasms was 42 HU.

2. No overlap was found in the attenuation characteristics of simple renal cysts and renal cell neoplasms.

Evidence Rating Level: 3 (Average)

Study Rundown: Cystic renal lesions are common incidental findings on CT and most commonly represent benign simple cysts. The diagnosis can be made on non-enhanced CT scans on cysts that display homogenous attenuation, antennation value between -10 and 20 HU, thin or imperceptible wall, and lack of other concerning feature (i.e. septa, nodules, calcifications). However, homogenous renal cysts with mean attenuation value between 20 and 30 HU on contrast-enhanced CT represent a challenge for radiologists to entirely exclude neoplasm, as concurrent non-contrast examinations are often not performed to evaluate for enhancement characteristics. The purpose of this study was to determine whether simple renal cysts and renal neoplasms can be differentiated on contrast-enhanced CT using attenuation and heterogeneity.

The study retrospectively reviewed the contrast-enhanced CT images of 125 patients with primary renal neoplasms. At the conclusion of the study, simple renal cysts were shown to have a mean attenuation of up to 30 HU.  Renal neoplasms were demonstrated to have a mean attenuation of at least 42 HU or higher, with no overlap between the cysts and neoplasm groups. The result of this trial suggests that homogenous cystic lesions on contrast-enhanced CT may not require further work-up if they have a mean attenuation of up to 30 HU. The study is limited by the small sample size. Other limitations include the lack of pathologic confirmation of renal cysts, and the small number of papillary RCC in the study (hypovascular neoplasms that may have attenuation overlap with simple cysts).

Click to read the study in AJR

Relevant Reading: The current radiological approach to renal cysts

RELATED REPORTS

Atezolizumab does not reduce post-resection recurrence in patients with renal cell carcinoma

CT associated with lower complication risks than invasive coronary angiography

Computed tomography a suitable diagnostic alternative for obstructive coronary artery disease

In-Depth [retrospective cohort]: The article retrospectively reviewed a pathology database from 2008 to 2014 for all cases of primary renal cell neoplasm. This was cross-referenced with data in PACS to obtain patients who underwent either CT of the abdomen with and without contrast (n=94) or only with contrast (n=31). Masses were subjectively determined as homogenous and heterogeneous by two experienced abdominal radiologists and differences were settled by consensus using the Cohen kappa test for inter-reader agreement. Attenuation was measured using as much of the region of interest (ROI) as possible for homogenous masses and the highest and lowest attenuation values were obtained in heterogeneous masses.

Overall, 116 heterogeneous renal cell neoplasms (99 clear cell, four papillary, four oncocytic, seven chromophobe, and two unclassified renal cell carcinomas), 13 homogenous renal cell neoplasms (10 papillary, two oncocytic, and one chromophobe), and 24 simple cysts were evaluated. All renal neoplasms were identically categorized as homogenous or heterogeneous (p=1.0, p<0.001). The lowest mean attenuation for homogenous renal cell neoplasms was 42 HU on contrast-enhanced CT and 32 HU on non-contrast CT. All heterogeneous renal cell neoplasms had a mean attenuation difference of >20 HU, with the exception of one with a difference of 19 HU but a high value of 105 HU. All simple renal cysts had a mean attenuation value of less than 30 HU.

Image: CC/Wiki/Narenfox

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Computed Tomography (CT)renal cell neoplasm
Previous Post

Interactive voice response system effective for CBT-based therapy for chronic back pain

Next Post

Prevalence of hypertension among adolescents varies by race and BMI

RelatedReports

Tenofovir disoprovil fumarate HIV prophylaxis linked with minimal kidney impact
Chronic Disease

Atezolizumab does not reduce post-resection recurrence in patients with renal cell carcinoma

October 11, 2022
PCI not superior to medical therapy alone in stable coronary disease: The COURAGE study
Cardiology

CT associated with lower complication risks than invasive coronary angiography

May 13, 2022
Patient Basics: Atherosclerosis
Cardiology

Computed tomography a suitable diagnostic alternative for obstructive coronary artery disease

March 14, 2022
#VisualAbstract: Internal mammary node irradiation improves survival for patients with centromedially located node-positive breast cancer
StudyGraphics

#VisualAbstract: Low-dose computed tomography improves the detection of secondary primary lung cancers compared to chest radiographs for head and neck cancer survivors

November 10, 2021
Next Post
Prevalence of hypertension among adolescents varies by race and BMI

Prevalence of hypertension among adolescents varies by race and BMI

Stochastic resonance stimulation may decrease apnea of prematurity

Low dose hydrocortisone not associated with adverse neurodevelopment in extremely preterm infants

Ultrasound-guided microwave ablation may be effective in severe secondary hyperparathyroidism

Trends in thyroid cancer incidence and mortality in the United States from 1974-2013

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • BNT162b2 booster is safe and reduces COVID-19 transmission in older adults
  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options